New guide explains how to achieve a healthy measurement system
Topics covered include why, how and when instruments should be calibrated to ensure they are delivering accurate measurement.
ABB has released a new guide explaining how to keep your instruments and analysers in top working condition. Titled ‘How to check whether your installed instrumentation is in need of a health check’, the guide covers the key factors to consider when assessing the operational performance of measurement equipment.
Topics covered include why, how and when instruments should be calibrated to ensure they are delivering accurate measurement. Many users mistakenly assume that the calibrated accuracy of an instrument will endure throughout its operational life, potentially resulting in incorrect measurements that could have a major impact on production and profitability. The section explains how to create an effective calibration regime and how to spot when an instrument may be in need of recalibration.
The guide also provides advice on the new possibilities being unlocked by advances in instrument technology, particularly when it comes to the availability of diagnostic data. The latest generation of smart digital instruments, coupled with developments in communication technology such as WirelessHART, have helped to unlock new possibilities for gaining quick and easy access to an expanded range of instrument data. Foremost amongst these is the ability to obtain a clearer picture of what is happening in a process. The ability to convey a greater range of data from a device at faster speeds over a digital network enables real or near real-time data to be obtained on process conditions, which can then be used to identify areas for possible improvement.
Other topics covered include guidance on inspecting instruments to check for deteriorating performance and tips for designing and implementing safety instrumented systems in critical safety applications.
“The scale and complexity of many industrial sites means that many companies may be unsure about the age, condition or even location of some of their installed instruments,” says Wayne Deeks for ABB UK Measurement & Analytics Service. “Our new guide aims to provide an easy to use point of reference for anyone looking to improve the performance of their process through more effective measurement.”
To obtain a copy of the guide, email [email protected] quoting reference ‘Health check guide’.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.